Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefepime vs Cefuroxime + Metronidazole Prophylaxis in C-Section
NCT04009772Phase 3Unknown
- Sponsor
- Assiut University
- Start
- Jul 2019
- Primary completion
- Feb 2020
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of cefepime in surgical site infection (SSI), sponsored by Assiut University. Status: unknown.
02
Drugs
cefepime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT04009772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04009772.